Hepatobiliary Surgery Practice Questions

Q: Which of the following tumors is typically found incidentally during investigations?

Hemangioma. **Explanation:** **Cavernous Hemangioma** is the most common benign tumor of the liver. It is typically a small, solitary lesion composed of blood-filled endothelial-lined spaces. The vast majority of hemangiomas are asymptomatic and do not undergo malignant transformation; therefore, they are most frequently discovered **incidentally** during abdominal imaging (USG or CT) performed for unrelated reasons. **Analysis of Options:** * **Adenoma (Option B):** While some are incidental, Hepatic Adenomas are clinically significant because they carry a risk of spontaneous rupture (causing intraperitoneal hemorrhage) and malignant transformation into Hepatocellular Carcinoma (HCC). They are strongly associated with oral contraceptive use. * **Hamartoma (Option C):** Mesenchymal hamartomas are rare benign tumors primarily seen in infants and young children. They often present as a rapidly enlarging abdominal mass rather than an incidental finding in adults. * **Lymphoma (Option D):** Primary hepatic lymphoma is extremely rare. Secondary involvement usually presents with systemic symptoms (B-symptoms), hepatomegaly, or abnormal liver function tests, making it unlikely to be a purely incidental finding. **High-Yield Clinical Pearls for NEET-PG:** * **Imaging Gold Standard:** Triple-phase CT shows **peripheral globular enhancement** with "centripetal filling" (delayed opacification toward the center). * **Management:** Most require no treatment. Surgery (enucleation or resection) is reserved only for very large ("Giant" >10cm) symptomatic lesions or those with a risk of rupture. * **Contraindication:** Percutaneous biopsy is generally avoided due to the high risk of hemorrhage. * **Kasabach-Merritt Syndrome:** A rare complication where a giant hemangioma causes consumptive coagulopathy and thrombocytopenia.

Q: Which of the following is not a major high-risk factor for cholangiocarcinoma?

Choledocholithiasis. **Explanation:** The development of cholangiocarcinoma (CCA) is strongly associated with conditions causing **chronic biliary inflammation and stasis**. **Why Choledocholithiasis is the correct answer:** While **Choledocholithiasis** (stones in the common bile duct) causes inflammation, it is generally **not** considered a major high-risk factor for cholangiocarcinoma. In contrast, **Hepatolithiasis** (intrahepatic stones) is a well-established major risk factor due to the prolonged, recurrent pyogenic cholangitis and mucosal dysplasia it induces. Simple ductal stones are common and rarely progress to malignancy compared to the other listed conditions. **Analysis of Incorrect Options:** * **Chronic Typhoid (A):** Chronic carriers of *Salmonella typhi* (especially those with gallbladder colonization) have a significantly increased risk of biliary tract cancers due to chronic bacterial irritation and the production of carcinogenic metabolites. * **C. sinensis infestation (C):** Liver flukes (*Clonorchis sinensis* and *Opisthorchis viverrini*) are Group 1 carcinogens. They cause chronic mechanical injury and inflammation of the bile duct epithelium, making them a leading cause of CCA in endemic regions (Southeast Asia). * **Ulcerative Colitis (D):** This is strongly associated with **Primary Sclerosing Cholangitis (PSC)**. PSC is the most common predisposing factor for cholangiocarcinoma in Western countries, with a lifetime risk of 10-15%. **High-Yield Facts for NEET-PG:** * **Most common site:** Perihilar (Klatskin tumor) is the most common location for CCA. * **Tumor Marker:** **CA 19-9** is the most commonly used marker for diagnosis and monitoring. * **Choledochal Cysts:** Type I and Type IV cysts carry the highest risk of malignant transformation. * **Risk Factor Mnemonic:** Remember the "S's": **S**tones (Intrahepatic), **S**clerosing Cholangitis, **S**almonella, and **S**pirit (Alcohol/Cirrhosis).

Q: Which of the following is the most common complication of this procedure?

Metabolic encephalopathy. ***Metabolic encephalopathy*** - **Hepatic encephalopathy** occurs in **25-35%** of patients post-TIPS due to bypassing hepatic metabolism of **nitrogenous compounds** like ammonia. - The shunt creates a direct connection between portal and systemic circulation, reducing the liver's ability to **detoxify** blood from the GI tract. *Shunt stenosis* - While **shunt stenosis** can occur, it is typically a **delayed complication** that develops over months to years, not the most common immediate issue. - Modern **covered stent grafts** have significantly reduced the incidence of stenosis compared to bare metal stents. *Capsular hemorrhage* - **Hepatic capsular hemorrhage** is a rare procedural complication occurring in less than **2-5%** of cases during needle puncture. - It is typically **self-limiting** and managed conservatively with observation and supportive care. *Recurrent variceal bleed* - **Recurrent bleeding** can occur if the shunt becomes **stenotic** or **occluded**, but this is a secondary complication rather than primary. - TIPS is specifically designed to **reduce portal pressure** and prevent variceal rebleeding, making this less common than encephalopathy.

Q: What is the most common type of gallbladder carcinoma associated with gallstones?

Adenocarcinoma. **Explanation:** **Gallbladder carcinoma (GBC)** is the most common biliary tract malignancy. The correct answer is **Adenocarcinoma** because it accounts for approximately **90-95%** of all gallbladder cancers. 1. **Why Adenocarcinoma is Correct:** The gallbladder is lined by columnar epithelium. Chronic irritation, most commonly due to **gallstones (cholelithiasis)**, leads to a sequence of metaplasia-dysplasia-carcinoma. Since the primary lining is glandular in nature, the resulting malignancy is almost always an adenocarcinoma. It can present in various forms, such as papillary, tubular, or mucinous. 2. **Why Other Options are Incorrect:** * **Anaplastic Carcinoma:** This is a rare, highly aggressive variant (approx. 2-3%) characterized by giant or spindle cells and carries a very poor prognosis. * **Squamous Cell Carcinoma:** This occurs in only 1-2% of cases. It arises from squamous metaplasia of the gallbladder lining, often due to chronic inflammation. * **Transitional Cell Carcinoma:** This is extremely rare in the gallbladder as this tissue type is characteristic of the urinary tract (urothelium). **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Gallstones are the most significant risk factor (found in 70-90% of cases). Other risks include **Porcelain Gallbladder** (intramural calcification), Choledochal cysts, and *Salmonella typhi* carrier state. * **Demographics:** It is more common in females (3:1 ratio) and shows a high prevalence in North India (Gangetic belt). * **Nevin’s Staging** and **AJCC TNM Staging** are used for prognosis. * **Investigation of Choice:** Contrast-Enhanced CT (CECT) is the gold standard for staging; Ultrasound is the initial screening tool.

Q: What incision approach is used for a mesocaval shunt?

Midline. **Explanation:** The **mesocaval shunt** is a portosystemic shunt performed to decompress portal hypertension by connecting the superior mesenteric vein (SMV) to the inferior vena cava (IVC), often using a synthetic H-graft. **Why Midline is correct:** The procedure requires extensive exposure of the retroperitoneum and the root of the mesentery. A **long midline incision** (from xiphoid to below the umbilicus) provides the best vertical access to both the SMV (located in the mesentery) and the infrarenal IVC (located retroperitoneally). It allows the surgeon to mobilize the transverse colon superiorly and the small bowel to the right to reach the vascular structures efficiently. **Why other options are incorrect:** * **Paramedian:** This incision is rarely used in modern vascular or hepatobiliary surgery as it is time-consuming to perform and offers no significant exposure advantage over the midline approach. * **Subcostal (Kocher’s):** While excellent for gallbladder or biliary tree surgery, a unilateral subcostal incision does not provide enough inferior exposure to reach the infrarenal IVC. * **Chevron (Bilateral Subcostal):** This is the gold standard for liver transplants and major hepatic resections. However, for a mesocaval shunt, the pathology is deeper in the mid-abdomen/retroperitoneum rather than the upper quadrants, making the midline incision more direct and less morbid. **High-Yield Clinical Pearls for NEET-PG:** * **Portocaval Shunt:** Usually performed via a **Right Subcostal** or **Chevron** incision (due to the high location of the portal vein). * **Distal Splenorenal Shunt (Warren Shunt):** Typically performed via a **Left Subcostal** or Midline incision. * **Indication:** Mesocaval shunts are often preferred in patients with previous upper abdominal surgery or those with a small diameter splenic vein.

Q: All of the following are known predisposing factors for cholangiocarcinoma except:

CBD stones. **Explanation:** The correct answer is **A. CBD stones**. While chronic irritation is a hallmark of cholangiocarcinoma (CCA) pathogenesis, simple Common Bile Duct (CBD) stones (choledocholithiasis) are generally not considered a direct independent risk factor for the development of CCA. In contrast, **intrahepatic stones (hepatolithiasis)** are strongly associated with the disease due to chronic recurrent pyogenic cholangitis. **Analysis of Options:** * **Clonorchis sinensis:** This liver fluke (along with *Opisthorchis viverrini*) is a classic risk factor. Chronic infection leads to biliary inflammation, hyperplasia, and eventual malignant transformation. * **Ulcerative Colitis (UC):** UC is indirectly linked via its strong association with Primary Sclerosing Cholangitis (PSC). Patients with UC have a significantly higher lifetime risk of developing CCA compared to the general population. * **Primary Sclerosing Cholangitis (PSC):** This is the most common predisposing factor for CCA in the Western world. About 10-15% of PSC patients will develop cholangiocarcinoma. **NEET-PG High-Yield Pearls:** * **Choledochal Cysts:** Type I and Type IV cysts carry the highest risk of malignancy; surgical excision is mandatory. * **Thorotrast:** A historical radiologic contrast agent strongly linked to CCA and Angiosarcoma of the liver. * **Tumor Marker:** **CA 19-9** is the most commonly used marker for monitoring, though it can be elevated in benign obstructive jaundice. * **Anatomy:** The most common site for CCA is the confluence of the hepatic ducts (**Klatskin Tumor**).

Q: Which of the following types of hydatid cyst denotes a complicated cyst?

Type IV. The classification of hydatid cysts is primarily based on the **Gharbi Classification** (ultrasound-based), which is crucial for determining management strategies. ### **Explanation of the Correct Answer** **Type IV** cysts are characterized as **solid or heterogenous masses** with no visible internal vesicles. This appearance represents a "pseudotumor" pattern. In the context of the Gharbi classification, Types I, II, and III are considered "active" or "simple" stages of the parasite's life cycle. **Type IV and Type V** are considered **complicated or inactive/degenerate** stages. Specifically, Type IV indicates that the parasite is dying or that the cyst has undergone internal degeneration, making it a "complicated" presentation compared to the clear, fluid-filled active stages. ### **Analysis of Incorrect Options** * **Type I (Option A):** Purely fluid-filled, unilocular collection. It is an **active** cyst (simple). * **Type II (Option B):** Characterized by fluid collection with a "split wall" (detached endocyst) or "water lily sign." It is an **active** cyst. * **Type III (Option C):** Multivesicular cyst with a "honeycomb" appearance due to daughter cysts. It is an **active/transitional** cyst. ### **NEET-PG High-Yield Pearls** * **Gharbi Classification Summary:** * **Type I:** Pure fluid (Active) * **Type II:** Detached membranes (Active) * **Type III:** Daughter cysts/Honeycomb (Active) * **Type IV:** Heterogenous/Solid (Degenerative/Complicated) * **Type V:** Calcified wall (Inactive/Dead) * **Treatment Choice:** Active cysts (I-III) often require PAIR (Puncture, Aspiration, Injection, Re-aspiration) or surgery, whereas Type IV and V are often managed with "watch and wait" unless symptomatic. * **Drug of Choice:** Albendazole (10-15 mg/kg/day) is the mainstay of medical therapy.

Question 1

Which of the following tumors is typically found incidentally during investigations?

Accepted Answer

Hemangioma

Answer

Adenoma

Answer

Hamartoma

Answer

Lymphoma

Question 2

Which of the following is not a major high-risk factor for cholangiocarcinoma?

Accepted Answer

Choledocholithiasis

Answer

Chronic typhoid

Answer

C. sinensis infestation

Answer

Ulcerative colitis

Question 3

Which of the following is the most common complication of this procedure?

Accepted Answer

Metabolic encephalopathy

Answer

Shunt stenosis

Answer

Capsular hemorrhage

Answer

Recurrent variceal bleed

Question 4

What is the most common type of gallbladder carcinoma associated with gallstones?

Accepted Answer

Adenocarcinoma

Answer

Anaplastic carcinoma

Answer

Squamous cell carcinoma

Answer

Transitional cell carcinoma

Question 5

What incision approach is used for a mesocaval shunt?

Accepted Answer

Midline

Answer

Paramedian

Answer

Subcostal

Answer

Chevron

Question 6

Which of the following originates at the hilum of the liver?

Accepted Answer

Klatskin tumor

Answer

Cholangiocarcinoma

Answer

Caroli disease

Answer

Primary sclerosing cholangitis

Question 7

What is Mirrizi syndrome?

Accepted Answer

Stone in the cystic duct compressing the common bile duct (CBD)

Answer

Cyst present in the common bile duct (CBD)

Answer

Obstruction of the pancreatic duct

Answer

Stone in the right hepatic duct

Question 8

All of the following are known predisposing factors for cholangiocarcinoma except:

Accepted Answer

CBD stones

Answer

Clonorchis sinensis

Answer

Ulcerative colitis

Answer

Primary sclerosing cholangitis

Question 9

Which of the following types of hydatid cyst denotes a complicated cyst?

Accepted Answer

Type IV

Answer

Type I

Answer

Type II

Answer

Type III

Question 10

Contraindications for resection in cholangiocarcinoma include all except:

Accepted Answer

Hepatic atrophy with ipsilateral bile duct involvement

Answer

Involvement of the main trunk of the portal vein

Answer

Hepatic atrophy with contralateral bile duct encasement

Answer

Hepatic atrophy with contralateral portal vein encasement

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?